Roivant Net Receivables from 2010 to 2024

ROIV Stock  USD 12.17  0.35  2.96%   
Roivant Sciences Net Receivables yearly trend continues to be fairly stable with very little volatility. Net Receivables is likely to outpace its year average in 2024. During the period from 2010 to 2024, Roivant Sciences Net Receivables regression line of quarterly data had mean square error of 407.5 T and geometric mean of  15,723,083. View All Fundamentals
 
Net Receivables  
First Reported
2010-12-31
Previous Quarter
82.8 M
Current Value
87 M
Quarterly Volatility
26.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Roivant Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Roivant Sciences' main balance sheet or income statement drivers, such as Discontinued Operations of 97.9 M, Depreciation And Amortization of 20.9 M or Interest Expense of 36.5 M, as well as many indicators such as Price To Sales Ratio of 116, Dividend Yield of 0.0 or PTB Ratio of 2.04. Roivant financial statements analysis is a perfect complement when working with Roivant Sciences Valuation or Volatility modules.
  
Check out the analysis of Roivant Sciences Correlation against competitors.
For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.

Latest Roivant Sciences' Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Roivant Sciences over the last few years. It is Roivant Sciences' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Roivant Sciences' overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Roivant Net Receivables Regression Statistics

Arithmetic Mean22,798,910
Geometric Mean15,723,083
Coefficient Of Variation114.81
Mean Deviation18,535,189
Median10,970,000
Standard Deviation26,175,652
Sample Variance685.2T
Range80.2M
R-Value0.67
Mean Square Error407.5T
R-Squared0.45
Significance0.01
Slope3,916,306
Total Sum of Squares9592.3T

Roivant Net Receivables History

202487 M
202382.8 M
202237.6 M
20216.7 M
202013.8 M
201915.3 M

About Roivant Sciences Financial Statements

Roivant Sciences investors use historical fundamental indicators, such as Roivant Sciences' Net Receivables, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Roivant Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Receivables82.8 M87 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Roivant Stock Analysis

When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.